Breast cancer vax promises early protection

Cleveland Clinic star investigator Dr. Vincent Tuohy is scouting for $16 million to help fund human trials of an experimental breast cancer vaccine designed to stop cancer from developing as a woman ages. With Dendreon's Provenge putting a spotlight on new therapeutic cancer vaccines, Tuohy wants to create a vaccine that works the way childhood vaccines do; protecting women from a lethal and all-too-common disease. Report

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.